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Objective: Few studies have sought to establish how often death after sepsis is related to the sepsis and
how often underlying diseases have a major role in case fatality.
Methods: In this retrospective cohort study, data were collected on 497 cases with blood culture-positive
sepsis in an emergency department (ED).
Results: Sepsis was categorized as severe in 31% of cases; 7% had septic shock. The quick Sepsis-related
Organ Failure Assessment score was positive in 136 out of 473 cases (29%). Ninety-eight patients died by
day 90; in 16 of these cases (16%) the death was sepsis-related in a patient without a rapidly fatal
underlying disease, in 45 cases (46%) the death was sepsis-related in a patient with a rapidly fatal
underlying disease, and in 37 cases (38%) the death was unrelated to sepsis. Sepsis-related death occurred
in 58 out of 61 cases (95%) by day 28.
Conclusions: Underlying diseases were found to have a considerable role in the death of patients suffering
from blood culture-positive sepsis in an ED of a developed country, as only 16% of the deaths by day
90 occurred where death was sepsis-related and the patient had a life-expectancy of more than 6 months.
Improving the outcome of sepsis with new treatments is thus challenging. It is possible that day 7 + day
28 mortality is a more appropriate endpoint than day 90 mortality when studying the outcome of sepsis,
as this time-span includes most of the patients whose death was related to sepsis.
© 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Sepsis is one of the leading causes of death worldwide. It has
been ranked as the eleventh most common cause of death in the
USA.1 Advanced age, immunosuppression, diabetes, and cancer are
major risk factors for sepsis.2–6 Prognostic factors for the severity
and outcome of sepsis include advanced age, type of infection (e.g.,
methicillin-resistant Staphylococcus aureus (MRSA), polymicro-
bial), number of organ dysfunctions, and adequacy of antimicrobial
therapy.7–9
Studies have been performed on sepsis patients in emergency
departments (EDs) and intensive care units (ICUs) in order to
determine risk factors for mortality9–13 and the aetiology of
illness.14 Less attention has been paid to the questions of how often
these patients actually die of sepsis, how often sepsis is a* Corresponding author. Tel: +358 3 31166747, Fax: +358 3 31164333.
E-mail address: juha.rannikko@gmail.com (J. Rannikko).
http://dx.doi.org/10.1016/j.ijid.2017.03.005
1201-9712/© 2017 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).contributory factor in the death of a patient with an advanced
underlying disease, and how often the death is independent of
sepsis.
In this retrospective cohort study, data were collected on 497
adult cases of blood culture-positive sepsis in the ED of Tampere
University Hospital (TAUH). A categorization of causes of death was
developed in order to establish how often death was related to
sepsis in patients without a rapidly fatal underlying disease (group
1), was related to sepsis by weakening of a patient with a rapidly
fatal underlying disease (group 2), and was independent of sepsis
but caused by the underlying disease (group 3). It was also sought
to determine the best cut-off among the commonly used days for
mortality used in sepsis research, i.e. day 7, day 28, or day 90, for
mortality related to sepsis (deaths in groups 1 and 2).
Materials and methods
TAUH is a tertiary hospital with a catchment population of
approximately 524 700 inhabitants in Pirkanmaa County. The ED ofciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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emergency care. In specialized care, the majority of patients are
internal medicine and surgical patients. Blood cultures are taken
routinely from patients with signs or symptoms of systemic
infection. The population of the present study comprised 497 adult
patients admitted to the ED of TAUH and treated in specialized
care, who had blood culture-positive sepsis during the period
March 1, 2012 to February 28, 2014. The study was approved by the
Ethics Committee of Tampere University Hospital. The need for
informed consent was waived, as no additional blood sampling
was needed and routine patient care was not modiﬁed.
TAUH has a 24-bed ICU which includes a seven-bed high
dependency unit (HDU). In this article, ‘ICU’ refers to both of these.
There are four other HDUs (cardiology, pulmonary, surgical, and
internal medicine), all taking care of sepsis patients; these are
referred to as ‘HDUs’.
Blood cultures were collected in BacT/Alert Aerobic (FA Plus)
and Anaerobic (FN Plus) blood culture bottles and placed in the
automated microbial detection system BacT/Alert 3D (bioMérieux,
Marcy l’Etoile, France). All patients with a positive blood culture
obtained during specialized care in the ED were identiﬁed in the
microbiology laboratory serving TAUH (Fimlab Laboratories plc).
Patient details, the name of the organism, and the date of blood
culture were collected by clinical microbiologists (T.S. and J.A.).
Cultures positive for coagulase-negative Staphylococcus, Propio-
nibacterium, Micrococcus, Bacillus, and Corynebacterium, with
detection in a single blood culture bottle and without clinical
relevance, were considered to be contaminants and were excluded.
Patients whose routine blood samples taken on admission were
no longer available for further studies were also excluded. This
could be due, for example, to the fact that the blood culture became
positive later than 72 h after the day of admission.
The clinical data for the patients included in the study were
gathered retrospectively from the patient records by the principal
investigator (J.R.). The site of infection was decided retrospectively
by the principal investigator based on clinical judgement. Sepsis
was deemed to be healthcare-associated if the symptoms had
started more than 48 h after admission to a healthcare institution,
or the bacteraemia was related to a surgical operation within the
preceding 30 days or some other invasive procedure within the
previous 10 days.15 Data on cause of death were gathered from
patient records (and autopsy records when applicable) by two
clinicians (J.R. and R.H.) independently. In cases of discrepancy, a
meeting was held together with a third clinician (J.S.) and a ﬁnal
decision was made.
Cause of death by day 90 was classiﬁed into three different
categories: (1) group 1 included cases of sepsis-related mortality in
patients without a rapidly fatal underlying disease. The immediate
cause of death in this group was sepsis, or sepsis was a factor in a
chain of events leading to death, and the patient had a life-
expectancy of more than 6 months. (2) Group 2 included cases of
sepsis-related mortality in patients with a rapidly fatal underlying
disease. In this group, the patient died of sepsis (immediate cause
of death, or sepsis was a factor in a chain of events leading to death)
by weakening of a patient with a rapidly fatal (<6 months)
underlying disease. (3) Group 3 included cases of mortality related
to underlying disease. In this group, sepsis was not an immediate
cause of death or a factor in a chain of events leading to death.
The categorization was based on clinical decision and the
judgement was based on the severity of the patient’s underlying
disease, the patient’s pre-performance, severity of the sepsis, and
recovery after the infection. The main underlying disease
associated with death was determined retrospectively by the
principal investigator.
Diagnoses of sepsis, severe sepsis, and septic shock were made
according to consensus deﬁnitions.16 Further, the quick Sepsis-related Organ Failure Assessment score (qSOFA) was calculated
post-hoc according to recently published deﬁnitions.17 The qSOFA
score was positive if at least two of the following three criteria
were fulﬁlled in the ED: respiratory rate 22/min, altered
mentation, and systolic blood pressure 100 mmHg. The McCabe
classiﬁcation was determined as reported by McCabe and
Jackson.18 The Pitt bacteraemia score was calculated as presented
by Korvick et al.19 IBM SPSS version 22.0 software (IBM Corp.,
Armonk, NY, USA) was used for the statistical analyses. Categorical
data were analyzed by Chi-square test, or Fisher’s exact test when
appropriate. Odds ratios (OR) with 95% conﬁdence intervals (95%
CI) are also presented.
Results
There were 800 consecutive positive blood cultures in adult
patients during the study period. One hundred and thirty-six of
these were considered to be contaminants and 167 were excluded
for other reasons. A total 497 cases of positive blood culture
among 484 patients were thus included. All 497 cases had sepsis.
During the study period, 11 patients had sepsis twice on different
admissions and one patient had sepsis three times. Of the total
study population, 262 (53%) were male and 235 (47%) were
female; they ranged in age from 16 to 95 years (median 68 years).
Table 1 provides the demographic data, data on the causative
organisms, and data on the underlying diseases stratiﬁed into six
different categories: groups 1, 2, and 3 (as noted in the Materials
and methods section), all patients who died, all patients who
survived, and all cases. For 16 out of 98 patients (16%) who died by
day 90, death was related to sepsis and the patient did not have a
rapidly fatal underlying disease (group 1), i.e. 3% of all 497 sepsis
cases. For 45 patients (46% of all deaths by day 90), death was
related to sepsis in that it weakened the patient leading to the
death, which was in any case expected as the patient had a rapidly
fatal underlying disease (group 2). For 37 patients (38%), death by
day 90 was unrelated to sepsis and was caused by an underlying
disease(s) in the patient (group 3).
Of the group 1 patients, four (25%) had alcohol abuse as an
underlying disease (Table 1). One was without any underlying
disease. Four of the patients in group 1 were over 80 years of age
(25%). Three group 1 patients (19%) were found lying at home with
a low level of consciousness and were transferred to hospital. In
group 2 patients, the rapidly fatal underlying disease was a solid
tumour with metastasis in eight cases (18%) and a haematological
malignancy in nine (20%). In group 3 patients, the cause of death
was a solid tumour with metastasis in 19 patients (51%) and a
haematological malignancy in two (5%). Thus, malignancies were
associated with death in 46% of patients in groups 2 and 3
combined. Other common rapidly fatal underlying diseases
associated with death among the patients in groups 2 and 3 were
liver disease (11%), heart disease (11%), and neurological/neuro-
surgical disease (10%).
The case fatality rate by day 7, day 28, and day 90 was 9%, 14%,
and 20%, respectively. Death occurred by day 7 in 94% of group 1
patients, in 56% of group 2 patients, and in 11% of group 3 patients
(Figure 1). All except two cases in group 2 died before day 28. The
deaths in group 3 occurred most often between day 29 and day 90
(68%). Ninety-ﬁve per cent of all sepsis-related deaths occurred
within 28 days after sepsis.
Table 2 gives data on the severity of sepsis stratiﬁed into the
same categories as used in Table 1. The qSOFA was positive in 136
out of 473 cases (29%). Group 1 had the highest Pitt bacteraemia
scores. Forty-eight (10%) cases were transferred from the ED to the
ICU and 52 (11%) to HDUs. Thus, the majority of sepsis patients and
the majority of qSOFA-positive cases were taken care of in general
wards. Out of 449 cases who were treated outside the ICU, 104
Table 1
Characteristics underlying diseases, and causative organisms in relation to the outcome.
Sepsis-related mortality in
patients without a rapidly
fatal underlying disease
(Group 1) (n = 16)
Sepsis-related mortality
in patients with a rapidly
fatal underlying disease
(Group 2) (n = 45)
Mortality related to
underlying disease
(Group 3) (n = 37)
All patients who
died (n = 98)
Patients who
survived
(n = 399)
All cases
(N = 497)
n (%) n (%) n (%) n (%) n (%) n (%)
Median age, years (range) 77 (51–94) 78 (42–93) 70 (44–91) 74 (42–94) 68 (16–95) 68 (16–95)
Male sex 8 (50) 24 (53) 25 (68) 57 (58) 205 (51) 262 (53)
Underlying diseases
Heart disease 8 (50) 23 (51) 10 (27) 41 (42) 135 (34) 176 (35)
Diabetes mellitus, any type 6 (38) 15 (33) 13 (35) 34 (34) 105 (26) 139 (28)
Neurological 5 (31) 14 (31) 9 (24) 28 (29) 84 (21) 112 (23)
Solid tumour with
metastasisa
1 (6) 10 (22) 17 (46) 28 (29) 29 (7) 57 (12)
Alcohol abuseb 4 (25) 5 (11) 8 (22) 17 (17) 35 (9) 52 (11)
Liver disease 3 (19) 8 (18) 6 (16) 17 (17) 32 (8) 49 (10)
Haematological malignancy 0 (0) 11 (24) 4 (11) 15 (15) 30 (8) 45 (9)
No underlying diseases 1 (6) 0 (0) 0 (0) 1(6) 70 (14) 71 (14)
Causative organismc
Gram-positive 5 (31) 18 (40) 13 (35) 36 (37) 189 (47) 225 (45)
Gram-negative 9 (56) 19 (42) 14 (38) 42 (43) 181 (45) 223 (45)
Escherichia coli urosepsis 3 (19) 6 (13) 3 (8) 12 (12) 85 (21) 97 (20)
Polymicrobial and anaerobes 2 (13) 8 (18) 10 (27) 20 (20) 28 (7) 48 (10)
a The most common solid tumour with metastasis was cancer of the gastrointestinal tract (36 cases).
b Social or medical problems of alcohol abuse in the past 12 months.
c Excluding fungi (n = 1).
54 J. Rannikko et al. / International Journal of Infectious Diseases 58 (2017) 52–57(23%) had severe sepsis and nine (2%) had septic shock. Of those
with septic shock, three died in the ED and the remainder had
underlying diseases that had progressed too far for them to beneﬁt
from treatment in the ICU.N=15
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of 98 patients who died within 90 days after sepsis. The percentage is per category of
Table 2
Severity of the sepsis in relation to the outcome.
Sepsis-related mortality in
patients without a rapidly fatal
underlying disease (Group 1)
(n = 16)
Sepsis-related mortality in
patients with a rapidly fatal
underlying disease (Group 2)
(n = 45)
Mortality related to
underlying disease
(Group 3) (n = 37)
All patients who
died (n = 98)
Patients who
survived (n = 399)
All cases
(N = 497)
n (%) n (%) n (%) n (%) n (%) n (%)
Severe sepsis 16 (100) 30 (67) 13 (35) 59 (60) 93 (23) 152 (31)
Septic shock 9 (56) 9 (20) 4 (11) 22 (22) 15 (4) 37 (7)
qSOFA-positivea 13 (81) 26 (59) 16 (46) 55 (58) 81 (21) 136 (29)
Admitted from ED to
ICU
11 (69) 7 (16) 3 (8) 21 (21) 27 (7) 48 (10)
Pitt bacteraemia scoreb
0–1 1 (6) 16 (36) 20 (57) 37 (39) 269 (68) 306 (62)
2–3 3 (19) 17 (39) 10 (29) 30 (32) 93 (24) 123 (25)
4 12 (75) 11 (25) 5 (14) 28 (29) 33 (8) 61 (12)
ED, emergency department; ICU, intensive care unit; qSOFA, quick sepsis-related organ failure assessment.
a Data available for 473 cases (95 who died and 378 who survived).
b Data available for 490 cases.
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previous use of immunosuppressive medications was common:
94 (19%) patients were taking corticosteroids (any dose) and 56
(11%) were on cancer chemotherapy. Antibiotics were started on
the day of admission in 93% of patients. The most common
antibiotic was cefuroxime (57%), followed by ceftriaxone (18%)
and ﬂuoroquinolone (11%). An antibiotic combination was
started in 16% of patients. The median time from admission to
the start of antibiotics was 174 min (range 0–1269 min).
Of all cases, 426 (86%) had one or more underlying diseases. As
shown in Table 1, there were signiﬁcantly more alcohol abusers in
group 1 as compared to those who survived for more than 90 days
(4/16 vs. 35/399; OR 3.8, 95% CI 1.2–12.4, p = 0.04). There were also
signiﬁcantly more patients with a solid tumour with metastasis
and patients with haematological malignancies among those who
died by day 90 than among survivors (28/98 vs. 29/399, OR 5.1, 95%Table 3
Causative organisms.
Organisms n (%)
Gram-positive 225 (45.3)
Staphylococcus aureus 74 (14.9)
MRSA 3 (0.6)
Coagulase-negative Staphylococcus 11 (2.2)
Streptococcus pneumoniae 52 (10.5)
b-haemolytic streptococci 45 (9.1)
Viridans streptococci 21 (4.2)
Enterococci 17 (3.4)
Other Gram-positive 5 (1.0)
Gram-negative 223 (44.9)
Escherichia coli 159 (32.0)
ESBL-E. coli 9 (1.8)
Klebsiella sp 21 (4.2)
ESBL-Klebsiella sp 0 (0.0)
Pseudomonas aeruginosa 18 (3.6)
Other Gram-negative 25 (5.0)
Others 49 (9.9)
Anaerobes 15 (3.0)
Fungi 1 (0.2)
Polymicrobial 33 (6.6)
All 497 (100)
MRSA, methicillin-resistant Staphylococcus aureus; ESBL, extended-
spectrum beta-lactamase.CI 2.9–9.1, p < 0.01 and 15/98 vs. 30/399, OR 2.2, 95% CI 1.1–4.3,
p = 0.02, respectively).
The causative organisms are listed in Table 3. Gram-positive and
Gram-negative organisms were equally common. There were few
cases with MRSA and extended-spectrum beta-lactamase-produc-
ing Enterobacteriaceae and no cases with vancomycin-resistant
enterococci or carbapenemase-producing Enterobacteriaceae.
Discussion
In this study, the case fatality rate by day 7, day 28, and day
90 was 9%, 14%, and 20%, respectively, in 497 cases with blood
culture-positive sepsis treated in an ED. The day 7 and day 28 case
fatality rates in this study are similar to those reported in a study by
Lin et al., who also studied bacteraemic patients in the ED.9 In two
other studies investigating the day 28 case fatality rate in
bacteraemic patients in the ED, Lee et al. reported a rate of 9%
and Kao et al. reported a rate of 19%.12,20
Only 16% of all deaths by day 90 in the present study were
related to sepsis in patients with a life-expectancy of more than 6
months (group 1). Forty-six percent of deaths occurred in patients
with a rapidly fatal underlying disease although death was sepsis-
related (group 2), and 38% of deaths were related to the underlying
disease (group 3). It is known that underlying diseases have a role
in the deaths of sepsis patients,2–4,9 but the categorization of the
present study gives a picture of the signiﬁcance of the underlying
diseases in these deaths.
Even patients in group 1 had many factors contributing to
death, for example alcoholism or very old age. There was only one
patient in this group without any underlying disease. It is possible
that there were patients in group 1 who sought treatment too late,
as three patients in this group were found lying at home with a low
level of consciousness. There were also signiﬁcantly more alcohol
abusers as compared to those who survived more than 90 days.
Altogether, in this cohort consisting mostly of community-
acquired cases seen in a university hospital ED in a developed
country, there were few non-survivors who would have had a life-
expectancy of more than 6 months and who might have beneﬁted
from a novel drug directed against sepsis or septic shock. This may
also explain why so many clinical trials in the ﬁeld of sepsis have
failed.21
Day 90 mortality has been used as the endpoint in many sepsis
studies.22–24 However, the present study showed that most (95%)
of the patients whose death was sepsis-related died within 28 days
after sepsis, while the majority of deaths occurring between day 28
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appropriate time-point to investigate sepsis-related mortality, as
regulatory agencies have indeed considered.21 Nonetheless, only
34% of deaths occurring between day 0 and day 7 were sepsis-
related in patients with a life-expectancy of more than 6 months.
Thus, even when day 7 and day 28 are used as endpoints for sepsis
mortality, deaths independent of sepsis are not ruled out.
This study has some limitations. By reason of the study design,
it was not possible to include all blood culture-positive cases
admitted to the ED during the study period. The potential
representativeness of the material was assessed by reviewing
the blood culture ﬁndings of those cases that were not included in
the study. Altogether there were 167 such cases (contaminants
excluded). The percentages of the most common blood culture
ﬁndings, S. aureus and Escherichia coli, did not differ between the
study population and the cases that were not included. It is thus
unlikely that missed cases would have had a major impact on the
results. Among cases not included in the material as compared to
those included, the percentage of anaerobes and other Gram-
negative organisms (see Table 3) was somewhat higher (9.0% vs.
3.0% and 10.2% vs. 5.0%, respectively) and the percentage of
Streptococcus pneumoniae was lower (4.2% vs. 10.5%). This may be
due to the long incubation period of anaerobes and other Gram-
negative organisms and the short incubation period of S. pneumo-
niae. Again, assuming that case fatality among missed cases with
anaerobes or other Gram-negatives would be approximately the
same as among those included in the study, the numbers would be
too low to alter the major ﬁndings of the study.
Only blood culture-positive cases were included, which would
exclude for example those with false-negative blood cultures. This
might also have led to a lower number of septic patients with
respiratory infection. However, it is also a strength that culture-
negative sepsis cases, which are difﬁcult to deﬁne, were not
included. Hence the material consists more of true infections than
patients who were for example only positive for systemic
inﬂammatory response syndrome (SIRS).
The material was gathered in a tertiary level hospital of a
developed country with a low incidence of multi-resistant
bacteria. These types of results cannot, therefore, be generalized
to low-income countries, as has been pointed out by Rello and
Leblebicioglu.25 It is possible that the role of the underlying
diseases would also have been different if the study patients had
been only from ICUs.
The method used to categorize the cause of death was
developed by the authors. It encompasses the classiﬁcation used
on the death certiﬁcate (immediate cause and underlying cause)
and combines it with the McCabe classiﬁcation of rapidly fatal
disease. This has limitations, since in some cases it was not easy to
decide whether the patient would have lived for more than 6
months without the sepsis or not. Even group 1 patients were
elderly and had many underlying diseases. However, the authors
believe that the categorization used is illustrative of the course of
events among these patients, and the use of two or three clinicians
to provide a judgement gives it sufﬁcient validity.
In conclusion, this study showed that patients with sepsis who
die within 90 days after sepsis in a developed country, die mostly
either of sepsis by weakening of the patient with a rapidly fatal (<6
months) underlying disease, or of the underlying disease itself.
This does not mean that sepsis patients do not need high-quality
care. Indeed, the low number of cases of sepsis-related mortality
among patients with a life-expectancy of more than 6 months may
be attributed to the good quality of the care these patients
received. When investigating sepsis-related mortality, day
28 should be used as the endpoint to identify most of the
sepsis-related mortality, while a large part of sepsis-independent
mortality is ruled out.Funding
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